Senate Drafts Plan To Speed Up FDA Drug Approval

Law360, New York (April 4, 2012, 9:26 PM EDT) -- A U.S. Senate committee on Wednesday released proposed legislation involving U.S. Food and Drug Administration approval processes that would expedite development of new, innovative medicines for serious and life-threatening diseases.

The Health, Education, Labor and Pensions Committee launched the bipartisan Drug Approval and Patient Access Plan discussion draft, presented as an amendment to the Food Drug and Cosmetic Act. The plan would enhance the FDA’s authority to consider various scientific data, methods and tools as a means of speeding up the development and access to novel treatments....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.